Necrobiosis Lipoidica, from the Skin Lesion to the Type 2 Diabetes Mellitus
DOI:
https://doi.org/10.60591/crspmi.80Keywords:
Diabetes Mellitus, Type 2/complication, Necrobiosis Lipoidica/diagnosis, Necrobiosis Lipoidica/etiologyAbstract
.
Downloads
References
Terziroli Beretta-Piccoli B, Mainetti C, Peeters MA, Laffitte E. Cutaneous Granulomatosis: a Comprehensive Review. Clin Rev Allergy Immunol. 2018;54:131-46. doi: 10.1007/s12016-017-8666-8.
Lepe K, Riley CA, Salazar FJ. Necrobiosis Lipoidica. In: StatPearls. Treasure Island: StatPearls Publishing; 2022. [accessed 2021 Aug 26]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459318/
Reid SD, Ladizinski B, Lee K, Baibergenova A, Alavi A. Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options. J Am Acad Dermatol. 2013;69:783-91. doi: 10.1016/j.jaad.2013.05.034.
Sibbald C, Reid S, Alavi A. Necrobiosis Lipoidica. Dermatol Clin. 2015;33:343-60. doi: 10.1016/j.det.2015.03.003.
Sanches MM, Roda Â, Pimenta R, Filipe PL, Freitas JP. Cutaneous Manifestations of Diabetes Mellitus and Prediabetes. Acta Med Port. 2019;32:459-65. doi: 10.20344/amp.10738.
Mistry BD, Alavi A, Ali S, Mistry N. A systematic review of the relationship between glycemic control and necrobiosis lipoidica diabeticorum in patients with diabetes mellitus. Int J Dermatol. 2017;56:1319-27. doi: 10.1111/ijd.13610.
